NanoTx Therapeutics is radiopharmaceutical company developing liposomally encapsulated radiotherapeutics for the treatment of cancer. Our technology allows high levels of radiation to be delivered to focused areas. The first in human clinical trial with 186RNL is now enrolling patients. Please see clinicaltrials.gov for further details regarding study sites and progress.
NanoTx Therapeutics © ALL RIGHTS RESERVED.